[HTML] springer.comFull View

[HTML][HTML] Incidence and outcomes of cancer treatment-related cardiomyopathy among referrals for advanced heart failure

R Araujo-Gutierrez, SH Ibarra-Cortez, JD Estep… - Cardio-oncology, 2018 - Springer
Abstract Background Approximately 2–3% of patients undergoing advanced heart failure
therapies such as left ventricular assist devices (LVAD) and orthotropic heart transplantation …
被引用次数：12 相关文章

Incidence and outcomes of cancer treatment-related cardiomyopathy among referrals for advanced heart failure

R Araujo-Gutierrez, SH Ibarra-Cortez, JD Estep… - Cardio …, 2018 - go.gale.com
Background Approximately 2-3% of patients undergoing advanced heart failure therapies
such as left ventricular assist devices (LVAD) and orthotropic heart transplantation (OHT) …

Incidence and outcomes of cancer treatment-related cardiomyopathy among referrals for advanced heart failure

R Araujo-Gutierrez, SH Ibarra-Cortez… - Cardio-oncology …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Approximately 2-3% of patients undergoing advanced heart failure therapies
such as left ventricular assist devices (LVAD) and orthotropic heart transplantation (OHT) …
[HTML] biomedcentral.com

[HTML][HTML] Incidence and outcomes of cancer treatment-related cardiomyopathy among referrals for advanced heart failure

R Araujo-Gutierrez… - Cardio …, 2018 - cardiooncologyjournal …
Approximately 2–3% of patients undergoing advanced heart failure therapies such as left
ventricular assist devices (LVAD) and orthotropic heart transplantation (OHT) have …

Incidence and outcomes of cancer treatment-related cardiomyopathy among referrals for advanced heart failure

R Araujo-Gutierrez, SH Ibarra-Cortez, JD Estep… - Cardio-Oncology, 2018 - infona.pl
Background Approximately 2–3% of patients undergoing advanced heart failure therapies
such as left ventricular assist devices (LVAD) and orthotropic heart transplantation (OHT) …

Incidence and outcomes of cancer treatment-related cardiomyopathy among referrals for advanced heart failure

R Araujo-Gutierrez, SH Ibarra-Cortez… - Cardio …, 2018 - search.proquest.com
Background Approximately 2–3% of patients undergoing advanced heart failure therapies
such as left ventricular assist devices (LVAD) and orthotropic heart transplantation (OHT) …
[PDF] scienceopen.com

[PDF][PDF] Incidence and outcomes of cancer treatment-related cardiomyopathy among referrals for advanced heart failure

R Araujo-Gutierrez, SH Ibarra-Cortez, JD Estep… - 2018 - scienceopen.com
Abstract Background: Approximately 2–3% of patients undergoing advanced heart failure
therapies such as left ventricular assist devices (LVAD) and orthotropic heart transplantation …
[HTML] nih.gov

[HTML][HTML] Incidence and outcomes of cancer treatment-related cardiomyopathy among referrals for advanced heart failure

R Araujo-Gutierrez, SH Ibarra-Cortez, JD Estep… - Cardio …, 2018 - ncbi.nlm.nih.gov
Background Approximately 2–3% of patients undergoing advanced heart failure therapies
such as left ventricular assist devices (LVAD) and orthotropic heart transplantation (OHT) …

Incidence and outcomes of cancer treatment-related cardiomyopathy among referrals for advanced heart failure.

R Araujo-Gutierrez, SH Ibarra-Cortez… - Cardio-oncology …, 2018 - europepmc.org
Background Approximately 2-3% of patients undergoing advanced heart failure therapies
such as left ventricular assist devices (LVAD) and orthotropic heart transplantation (OHT) …
[PDF] biomedcentral.com

[PDF][PDF] Incidence and outcomes of cancer treatment-related cardiomyopathy among referrals for advanced heart failure

R Araujo-Gutierrez, SH Ibarra-Cortez, JD Estep… - 2018 - cardiooncologyjournal …
Abstract Background: Approximately 2–3% of patients undergoing advanced heart failure
therapies such as left ventricular assist devices (LVAD) and orthotropic heart transplantation …